The Current Ratio as of November 2024 (TTM) for Bio-Path Holdings, Inc. (BPTH) is 0.86

According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.86. This represents a change of -24.52% compared to the average of 1.14 of the last 4 quarters.

Bio-Path Holdings, Inc. (BPTH) Historical Current Ratio (quarterly & annually)

How has BPTH Current Ratio performed in the past?

The mean historical Current Ratio of Bio-Path Holdings, Inc. over the last ten years is 12.61. The current 0.86 Current Ratio has changed 581.17% with respect to the historical average. Over the past ten years (40 quarters), BPTH's Current Ratio was at its highest in in the December 2021 quarter at 27.29. The Current Ratio was at its lowest in in the March 2024 quarter at 0.43.

Bio-Path Holdings, Inc. (BPTH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Path Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Path Holdings, Inc. (BPTH) Average Current Ratio

How has BPTH Current Ratio performed in the past?

The current Current Ratio of Bio-Path Holdings, Inc. (BPTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bio-Path Holdings, Inc. (BPTH) Current Ratio vs. Peers

How is BPTH’s Current Ratio compared to its peers?

Bio-Path Holdings, Inc.’s Current Ratio is greater than Catalyst Biosciences, Inc. (0), less than Diffusion Pharmaceuticals Inc. (10.96), less than Capricor Therapeutics, Inc. (4.19), less than NextCure, Inc. (9.07), less than Pulmatrix, Inc. (19.40), less than Bellerophon Therapeutics, Inc. (3.96), less than Crinetics Pharmaceuticals, Inc. (16.38), less than Applied Molecular Transport Inc. (4.99), less than Aileron Therapeutics, Inc. (3.30), less than Benitec Biopharma Inc. (15.01), less than Onconova Therapeutics, Inc. (1.93), less than Moleculin Biotech, Inc. (2.08), less than Achieve Life Sciences, Inc. (6.78), less than Icosavax, Inc. (18.06), greater than Akari Therapeutics, Plc (0.29),

Build a custom stock screener for Bio-Path Holdings, Inc. (BPTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Path Holdings, Inc. (BPTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.